Cargando…

Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families

BACKGROUND: Ataxia telangiectasia-mutated and Rad3-related (ATR) is a member of the PIK-related family which plays, along with ATM, a central role in cell-cycle regulation. ATR has been shown to phosphorylate several tumor suppressors like BRCA1, CHEK1 and TP53. ATR appears as a good candidate breas...

Descripción completa

Detalles Bibliográficos
Autores principales: Durocher, Francine, Labrie, Yvan, Soucy, Penny, Sinilnikova, Olga, Labuda, Damian, Bessette, Paul, Chiquette, Jocelyne, Laframboise, Rachel, Lépine, Jean, Lespérance, Bernard, Ouellette, Geneviève, Pichette, Roxane, Plante, Marie, Tavtigian, Sean V, Simard, Jacques
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1599749/
https://www.ncbi.nlm.nih.gov/pubmed/17010193
http://dx.doi.org/10.1186/1471-2407-6-230
_version_ 1782130442530455552
author Durocher, Francine
Labrie, Yvan
Soucy, Penny
Sinilnikova, Olga
Labuda, Damian
Bessette, Paul
Chiquette, Jocelyne
Laframboise, Rachel
Lépine, Jean
Lespérance, Bernard
Ouellette, Geneviève
Pichette, Roxane
Plante, Marie
Tavtigian, Sean V
Simard, Jacques
author_facet Durocher, Francine
Labrie, Yvan
Soucy, Penny
Sinilnikova, Olga
Labuda, Damian
Bessette, Paul
Chiquette, Jocelyne
Laframboise, Rachel
Lépine, Jean
Lespérance, Bernard
Ouellette, Geneviève
Pichette, Roxane
Plante, Marie
Tavtigian, Sean V
Simard, Jacques
author_sort Durocher, Francine
collection PubMed
description BACKGROUND: Ataxia telangiectasia-mutated and Rad3-related (ATR) is a member of the PIK-related family which plays, along with ATM, a central role in cell-cycle regulation. ATR has been shown to phosphorylate several tumor suppressors like BRCA1, CHEK1 and TP53. ATR appears as a good candidate breast cancer susceptibility gene and the current study was designed to screen for ATR germline mutations potentially involved in breast cancer predisposition. METHODS: ATR direct sequencing was performed using a fluorescent method while widely available programs were used for linkage disequilibrium (LD), haplotype analyses, and tagging SNP (tSNP) identification. Expression analyses were carried out using real-time PCR. RESULTS: The complete sequence of all exons and flanking intronic sequences were analyzed in DNA samples from 54 individuals affected with breast cancer from non-BRCA1/2 high-risk French Canadian breast/ovarian families. Although no germline mutation has been identified in the coding region, we identified 41 sequence variants, including 16 coding variants, 3 of which are not reported in public databases. SNP haplotypes were established and tSNPs were identified in 73 healthy unrelated French Canadians, providing a valuable tool for further association studies involving the ATR gene, using large cohorts. Our analyses led to the identification of two novel alternative splice transcripts. In contrast to the transcript generated by an alternative splicing site in the intron 41, the one resulting from a deletion of 121 nucleotides in exon 33 is widely expressed, at significant but relatively low levels, in both normal and tumoral cells including normal breast and ovarian tissue. CONCLUSION: Although no deleterious mutations were identified in the ATR gene, the current study provides an haplotype analysis of the ATR gene polymorphisms, which allowed the identification of a set of SNPs that could be used as tSNPs for large-scale association studies. In addition, our study led to the characterization of a novel Δ33 splice form, which could generate a putative truncated protein lacking several functional domains. Additional studies in large cohorts and other populations will be needed to further evaluate if common and/or rare ATR sequence variants can be associated with a modest or intermediate breast cancer risk.
format Text
id pubmed-1599749
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-15997492006-10-12 Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families Durocher, Francine Labrie, Yvan Soucy, Penny Sinilnikova, Olga Labuda, Damian Bessette, Paul Chiquette, Jocelyne Laframboise, Rachel Lépine, Jean Lespérance, Bernard Ouellette, Geneviève Pichette, Roxane Plante, Marie Tavtigian, Sean V Simard, Jacques BMC Cancer Research Article BACKGROUND: Ataxia telangiectasia-mutated and Rad3-related (ATR) is a member of the PIK-related family which plays, along with ATM, a central role in cell-cycle regulation. ATR has been shown to phosphorylate several tumor suppressors like BRCA1, CHEK1 and TP53. ATR appears as a good candidate breast cancer susceptibility gene and the current study was designed to screen for ATR germline mutations potentially involved in breast cancer predisposition. METHODS: ATR direct sequencing was performed using a fluorescent method while widely available programs were used for linkage disequilibrium (LD), haplotype analyses, and tagging SNP (tSNP) identification. Expression analyses were carried out using real-time PCR. RESULTS: The complete sequence of all exons and flanking intronic sequences were analyzed in DNA samples from 54 individuals affected with breast cancer from non-BRCA1/2 high-risk French Canadian breast/ovarian families. Although no germline mutation has been identified in the coding region, we identified 41 sequence variants, including 16 coding variants, 3 of which are not reported in public databases. SNP haplotypes were established and tSNPs were identified in 73 healthy unrelated French Canadians, providing a valuable tool for further association studies involving the ATR gene, using large cohorts. Our analyses led to the identification of two novel alternative splice transcripts. In contrast to the transcript generated by an alternative splicing site in the intron 41, the one resulting from a deletion of 121 nucleotides in exon 33 is widely expressed, at significant but relatively low levels, in both normal and tumoral cells including normal breast and ovarian tissue. CONCLUSION: Although no deleterious mutations were identified in the ATR gene, the current study provides an haplotype analysis of the ATR gene polymorphisms, which allowed the identification of a set of SNPs that could be used as tSNPs for large-scale association studies. In addition, our study led to the characterization of a novel Δ33 splice form, which could generate a putative truncated protein lacking several functional domains. Additional studies in large cohorts and other populations will be needed to further evaluate if common and/or rare ATR sequence variants can be associated with a modest or intermediate breast cancer risk. BioMed Central 2006-09-29 /pmc/articles/PMC1599749/ /pubmed/17010193 http://dx.doi.org/10.1186/1471-2407-6-230 Text en Copyright © 2006 Durocher et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Durocher, Francine
Labrie, Yvan
Soucy, Penny
Sinilnikova, Olga
Labuda, Damian
Bessette, Paul
Chiquette, Jocelyne
Laframboise, Rachel
Lépine, Jean
Lespérance, Bernard
Ouellette, Geneviève
Pichette, Roxane
Plante, Marie
Tavtigian, Sean V
Simard, Jacques
Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families
title Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families
title_full Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families
title_fullStr Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families
title_full_unstemmed Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families
title_short Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families
title_sort mutation analysis and characterization of atr sequence variants in breast cancer cases from high-risk french canadian breast/ovarian cancer families
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1599749/
https://www.ncbi.nlm.nih.gov/pubmed/17010193
http://dx.doi.org/10.1186/1471-2407-6-230
work_keys_str_mv AT durocherfrancine mutationanalysisandcharacterizationofatrsequencevariantsinbreastcancercasesfromhighriskfrenchcanadianbreastovariancancerfamilies
AT labrieyvan mutationanalysisandcharacterizationofatrsequencevariantsinbreastcancercasesfromhighriskfrenchcanadianbreastovariancancerfamilies
AT soucypenny mutationanalysisandcharacterizationofatrsequencevariantsinbreastcancercasesfromhighriskfrenchcanadianbreastovariancancerfamilies
AT sinilnikovaolga mutationanalysisandcharacterizationofatrsequencevariantsinbreastcancercasesfromhighriskfrenchcanadianbreastovariancancerfamilies
AT labudadamian mutationanalysisandcharacterizationofatrsequencevariantsinbreastcancercasesfromhighriskfrenchcanadianbreastovariancancerfamilies
AT bessettepaul mutationanalysisandcharacterizationofatrsequencevariantsinbreastcancercasesfromhighriskfrenchcanadianbreastovariancancerfamilies
AT chiquettejocelyne mutationanalysisandcharacterizationofatrsequencevariantsinbreastcancercasesfromhighriskfrenchcanadianbreastovariancancerfamilies
AT laframboiserachel mutationanalysisandcharacterizationofatrsequencevariantsinbreastcancercasesfromhighriskfrenchcanadianbreastovariancancerfamilies
AT lepinejean mutationanalysisandcharacterizationofatrsequencevariantsinbreastcancercasesfromhighriskfrenchcanadianbreastovariancancerfamilies
AT lesperancebernard mutationanalysisandcharacterizationofatrsequencevariantsinbreastcancercasesfromhighriskfrenchcanadianbreastovariancancerfamilies
AT ouellettegenevieve mutationanalysisandcharacterizationofatrsequencevariantsinbreastcancercasesfromhighriskfrenchcanadianbreastovariancancerfamilies
AT pichetteroxane mutationanalysisandcharacterizationofatrsequencevariantsinbreastcancercasesfromhighriskfrenchcanadianbreastovariancancerfamilies
AT plantemarie mutationanalysisandcharacterizationofatrsequencevariantsinbreastcancercasesfromhighriskfrenchcanadianbreastovariancancerfamilies
AT tavtigianseanv mutationanalysisandcharacterizationofatrsequencevariantsinbreastcancercasesfromhighriskfrenchcanadianbreastovariancancerfamilies
AT simardjacques mutationanalysisandcharacterizationofatrsequencevariantsinbreastcancercasesfromhighriskfrenchcanadianbreastovariancancerfamilies